C-C Motif Chemokine Ligand 5 (CCL5): A Potential Biomarker and Immunotherapy Target for Osteosarcoma.

Zheng, Heng; Wang, Yichong; Li, Fengfeng

Zheng, Heng; Wang, Yichong; Li, Fengfeng.

Affiliation

Zheng H; The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, China.
Wang Y; Department of Orthopedics, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Li F; Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.

Curr Cancer Drug Targets ; 24(3): 308-318, 2024.

Article in En | MEDLINE | ID: mdl-37581517

Subject(s)

Bone Neoplasms; Osteosarcoma; Humans; Ligands; Osteosarcoma/diagnosis; Osteosarcoma/genetics; Osteosarcoma/therapy; Biomarkers; Immunotherapy; Bone Neoplasms/diagnosis; Bone Neoplasms/genetics; Bone Neoplasms/therapy; Chemokine CCL5/genetics

Key words

CCL5; Osteosarcoma (OS); bioinformatic analysis; biomarker.; diagnosis; immune-cell infiltration

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Bone Neoplasms / Osteosarcoma Type of study: Prognostic_studies / Screening_studies Limits: Humans Language: En Year: 2024 Type: Article

Fulltext

XML

PubMed Links

Search on Google